These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 26655639

  • 1. The Clinical Profile of Kawasaki Disease in Algerian Children: A Single Institution Experience.
    Boudiaf H, Achir M.
    J Trop Pediatr; 2016 Apr; 62(2):139-43. PubMed ID: 26655639
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.
    Maric LS, Knezovic I, Papic N, Mise B, Roglic S, Markovinovic L, Tesovic G.
    Rheumatol Int; 2015 Jun; 35(6):1053-8. PubMed ID: 25429794
    [Abstract] [Full Text] [Related]

  • 3. Risk factors for coronary artery lesions in children with Kawasaki disease.
    Duan J, Jiang H, Lu M.
    Arch Argent Pediatr; 2020 Oct; 118(5):327-331. PubMed ID: 32924395
    [Abstract] [Full Text] [Related]

  • 4. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, Chen QJ, Cheng PX.
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
    [Abstract] [Full Text] [Related]

  • 5. Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study.
    Wang Z, Weng F, Li C, Shi H, Tang Z, Qiu H, He Y, Wu R, Chu M.
    BMC Pediatr; 2018 Feb 21; 18(1):76. PubMed ID: 29466965
    [Abstract] [Full Text] [Related]

  • 6. A 10-year cross-sectional retrospective study on Kawasaki disease in Iranian children: incidence, clinical manifestations, complications, and treatment patterns.
    Sadeghi P, Izadi A, Mojtahedi SY, Khedmat L, Jafari M, Afshin A, Yarahmadi P, Hosseinali Beigi E.
    BMC Infect Dis; 2021 Apr 19; 21(1):368. PubMed ID: 33874899
    [Abstract] [Full Text] [Related]

  • 7. [Risk factors for coronary artery lesions in children with Kawasaki disease].
    Li Y, Wang XM, Liu YL, Shi K, Yang YF, Guo YH.
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec 19; 14(12):938-41. PubMed ID: 23234782
    [Abstract] [Full Text] [Related]

  • 8. [Risk factors for coronary artery lesions secondary to Kawasaki disease in children].
    Deng YC, Wang X, Tang XC, Huang CZ, Yang J, Mo LY.
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Sep 19; 17(9):927-31. PubMed ID: 26412172
    [Abstract] [Full Text] [Related]

  • 9. Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin.
    Platt B, Belarski E, Manaloor J, Ofner S, Carroll AE, John CC, Wood JB.
    JAMA Netw Open; 2020 Jan 03; 3(1):e1918565. PubMed ID: 31899532
    [Abstract] [Full Text] [Related]

  • 10. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
    Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED.
    Pediatr Cardiol; 2003 Jan 03; 24(2):122-6. PubMed ID: 12457252
    [Abstract] [Full Text] [Related]

  • 11. [Clinical features of recurrent Kawasaki disease in 20 children].
    Zou LX, Gong FQ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct 03; 10(5):617-9. PubMed ID: 18947484
    [Abstract] [Full Text] [Related]

  • 12. Kawasaki disease in New Zealand.
    Heaton P, Wilson N, Nicholson R, Doran J, Parsons A, Aiken G.
    J Paediatr Child Health; 2006 Apr 03; 42(4):184-90. PubMed ID: 16630319
    [Abstract] [Full Text] [Related]

  • 13. [Kawasaki disease in children--9 years experience].
    Kowalczyk M, Kawalec W, Daszkowska-York J, Turska-Kmieć A, Brzezińska-Rajszys G, Sobielarska D, Ziółkowska L, Kościesza A, Jagiełłowicz D, Mirecka-Rola A.
    Med Wieku Rozwoj; 2005 Apr 03; 9(2):179-93. PubMed ID: 16085959
    [Abstract] [Full Text] [Related]

  • 14. Plasma MASP-1 concentration and its relationship to recovery from coronary artery lesion in children with Kawasaki disease.
    Song RX, Zou QM, Li XH, Xu NP, Zhang T, Fu J, Cui XD.
    Pediatr Res; 2016 Feb 03; 79(2):301-7. PubMed ID: 26536449
    [Abstract] [Full Text] [Related]

  • 15. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM, Silverman ED, McCrindle BW, Yeung RS.
    J Pediatr; 2002 Apr 03; 140(4):450-5. PubMed ID: 12006960
    [Abstract] [Full Text] [Related]

  • 16. Outcomes of Kawasaki Disease: A Single-Center Experience.
    Uysal F, Bostan OM, Celebi S, Uysal B, Hamitoglu S, Cil E.
    Clin Pediatr (Phila); 2015 Jun 03; 54(6):579-84. PubMed ID: 25475592
    [Abstract] [Full Text] [Related]

  • 17. Epidemiologic Features of Kawasaki Disease in Shanghai From 2008 Through 2012.
    Chen JJ, Ma XJ, Liu F, Yan WL, Huang MR, Huang M, Huang GY, Shanghai Kawasaki Disease Research Group.
    Pediatr Infect Dis J; 2016 Jan 03; 35(1):7-12. PubMed ID: 26372452
    [Abstract] [Full Text] [Related]

  • 18. [Kawasaki disease: what you need to know].
    Bajolle F, Laux D.
    Arch Pediatr; 2012 Nov 03; 19(11):1264-8. PubMed ID: 22921712
    [Abstract] [Full Text] [Related]

  • 19. Coronary risk factors in Kawasaki disease treated with additional gammaglobulin.
    Miura M, Ohki H, Tsuchihashi T, Yamagishi H, Katada Y, Yamada K, Yamashita Y, Sugaya A, Komiyama O, Shiro H.
    Arch Dis Child; 2004 Aug 03; 89(8):776-80. PubMed ID: 15269082
    [Abstract] [Full Text] [Related]

  • 20. Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China.
    Ruan Y, Ye B, Zhao X.
    Pediatr Infect Dis J; 2013 Oct 03; 32(10):e397-402. PubMed ID: 23722531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.